AHMA
Ambitions Enterprise Management Co. L.L.C
There isn't enough reported data to score AHMA yet.
RIVN
Rivian Automotive, Inc.
RIVN lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
AHMA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Unavailable |
AHMA's profitability is currently healthy. There isn't enough data to rate its revenue, cash flow and balance sheet.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
AHMA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 29x | $1.16 | -0.8% |
| Current | 29x | $1.17 | — |
| Fair | 35x | $1.42 | +21% |
| Expensive | 96x | $3.82 | +227% |
Historical ranges are pointers, not guarantees.
AHMA's PE is 29x, but its earnings don't support one, so it isn't a reliable read right now.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
AHMA Forward outlook
There aren't enough analyst estimates for AHMA to show an outlook.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RIVN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
AHMA Earnings Per Share
AHMA and RIVN do not have enough comparable growth data to identify a winner.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
AHMA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $20.2M | +641% |
| Q4 2024 | $2.7M | -25% |
| Q2 2024 | $2.3M | +61% |
| Q4 2023 | $3.6M | +66% |
| Q2 2023 | $1.4M | +60% |
AHMA has the edge over RIVN in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 6.4% | +5.8 points |
| Q4 2024 | 9.2% | -2.2 points |
| Q2 2024 | 1.5% | -9.6 points |
| Q4 2023 | 10% | N/A |
| Q2 2023 | 0.6% | N/A |
| Q4 2022 | 11% | N/A |
| Q2 2022 | 11% | N/A |
AHMA's operating margin was 6.4% last quarter, up 5.8 points from the same quarter a year ago.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN's revenue is growing: $2.2B last quarter, up 38% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
AHMA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$1.1M | -646% |
| Q4 2024 | $202.1K | +$317.4K |
| Q2 2024 | $104.3K | +68% |
| Q4 2023 | -$115.2K | -439% |
| Q2 2023 | $61.9K | +$323.5K |
AHMA and RIVN do not have enough comparable growth data to identify a winner.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
AHMA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.9% | -1.2M shares |
| 1 year | -3.9% | -1.2M shares |
AHMA has the edge over RIVN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q2 2024 | — |
| Q4 2023 | — |
| Q2 2023 | — |
| Q4 2022 | — |
| Q2 2022 | — |
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has 1.4B diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
AHMA Net Leverage
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AHMA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.0 | Neutral |
| Stochastic | 10.6 | Oversold |
AHMA's weekly RSI is 44 (neutral) and its Stochastic is 11 (oversold).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
AHMA PE vs Consumer Cyclical Sector
| Metric | AHMA | Sector median | Relative |
|---|---|---|---|
| PE | 29x | 18x | 62% above |
| PE % | 19 | 13 | 6 pts above |
AHMA is trading at 29x earnings, a 62% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
AHMA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.21 | 3.3% below |
| 20 week MA | $1.45 | 19% below |
| 50 week MA | $4.31 | 73% below |
RIVN has stronger trend alignment. AHMA is above 0 of 3 weekly averages versus RIVN above 0 of 5.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
AHMA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $4.46 | $7.38 | +65% |
| 2026 YTD | $7.38 | $1.17 | -84% |
AHMA has finished every year since 2025 higher, and it's down 84% so far in 2026.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has the edge over AHMA on returns for 2026, with the stronger performance.